134 related articles for article (PubMed ID: 7351495)
1. Plasma levels of 8-methoxypsoralen determined by high-pressure liquid chromatography in psoriatic patients ingesting drug from two manufacturers.
Ljunggren B; Carter DM; Albert J; Reid T
J Invest Dermatol; 1980 Jan; 74(1):59-62. PubMed ID: 7351495
[TBL] [Abstract][Full Text] [Related]
2. 8-MOP plasma levels in PUVA problem cases with psoriasis.
Wagner G; Hofmann C; Busch U; Schmid J; Plewig G
Br J Dermatol; 1979 Sep; 101(3):285-92. PubMed ID: 508594
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralen.
Neild VS; Scott LV
Br J Dermatol; 1982 Feb; 106(2):199-203. PubMed ID: 7059510
[TBL] [Abstract][Full Text] [Related]
4. Standardizing 8-methoxypsoralen plasma profiles by using an emulsion form.
Van Boven M; Roelandts R; Adriaens P; Daenens P; Degreef H; Kinget R
J Am Acad Dermatol; 1985 May; 12(5 Pt 1):822-7. PubMed ID: 4008686
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of 8-methoxypsoralen and phototoxicity studies during PUVA treatment of psoriasis with meladinin tablets.
Thune P
Acta Derm Venereol; 1978; 58(2):149-51. PubMed ID: 76395
[TBL] [Abstract][Full Text] [Related]
6. Dose-response relations in phototoxicity due to 8-methoxypsoralen and UV-A in man.
Ljunggren B; Bjellerup M; Carter DM
J Invest Dermatol; 1981 Feb; 76(2):73-5. PubMed ID: 7462679
[TBL] [Abstract][Full Text] [Related]
7. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis.
Hönigsmann H; Jaschke E; Gschnait F; Brenner W; Fritsch P; Wolff K
Br J Dermatol; 1979 Oct; 101(4):369-78. PubMed ID: 508604
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and routine application of the novel restricted-access precolumn packing material Alkyl-Diol Silica: coupled-column high-performance liquid chromatographic analysis of the photoreactive drug 8-methoxypsoralen in plasma.
Vielhauer S; Rudolphi A; Boos KS; Seidel D
J Chromatogr B Biomed Appl; 1995 Apr; 666(2):315-22. PubMed ID: 7633608
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatographic determination of methoxsalen in plasma after liquid-solid extraction.
Kucová D; Marysková D; Davídková P; Gasparic J
J Chromatogr; 1993 May; 614(2):340-4. PubMed ID: 8314948
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of 8-methoxypsoralen during extracorporeal photochemotherapy: evidence for a "first-dose" effect.
Jacolot A; Tod M; Heudes AM; Petitjean O; Laroche L
Ther Drug Monit; 1996 Jun; 18(3):234-9. PubMed ID: 8738761
[TBL] [Abstract][Full Text] [Related]
11. Intraindividual variations of 8-methoxypsoralen plasma levels.
Schäfer-Korting M; Korting HC
Arch Dermatol Res; 1982; 272(1-2):1-7. PubMed ID: 7165313
[TBL] [Abstract][Full Text] [Related]
12. Photochemotherapy (PUVA) and psoriasis: comparison of 8-MOP and 8-MOP/5-MOP.
Langner A; Wolska H; Kowalski J; Duralska H; Murawska E
Int J Dermatol; 1976 Nov; 15(9):688-9. PubMed ID: 977210
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of 8-methoxypsoralen after bath-PUVA for psoriasis: relationship to disease severity.
Gómez MI; Azaña JM; Arranz I; Harto A; Ledo A
Br J Dermatol; 1995 Jul; 133(1):37-40. PubMed ID: 7669638
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of 8-methoxypsoralen following PUVA-bath photochemotherapy.
von Kobyletzki G; Hoffmann K; Kerscher M; Altmeyer P
Photodermatol Photoimmunol Photomed; 1998; 14(3-4):136-8. PubMed ID: 9779504
[TBL] [Abstract][Full Text] [Related]
15. Dietary influences on 8-MOP plasma levels in PUVA patients with psoriasis.
Roelandts R; Van Boven M; Deheyn T; Vander Stichele G; Degreef H; Daenens P
Br J Dermatol; 1981 Nov; 105(5):569-72. PubMed ID: 7295571
[TBL] [Abstract][Full Text] [Related]
16. Photochemotherapy of psoriasis with relevance to 8-methoxypsoralen plasma level and low intensity irradiation.
Thune P; Volden G
Acta Derm Venereol; 1977; 57(4):351-5. PubMed ID: 70930
[TBL] [Abstract][Full Text] [Related]
17. Microenema of 8-methoxypsoralen in photochemotherapy of psoriasis.
Siddiqui AH; Stolk L; Korthals Altes-Levij van Vinninghe HR; Kammeijer A; Cormane RH
Arch Dermatol Res; 1982; 273(3-4):219-23. PubMed ID: 7165351
[TBL] [Abstract][Full Text] [Related]
18. Rapid and sensitive analysis of 8-methoxypsoralen in plasma.
Gasparro FP; Battista J; Song J; Edelson RL
J Invest Dermatol; 1988 Feb; 90(2):234-6. PubMed ID: 3339265
[TBL] [Abstract][Full Text] [Related]
19. [Influence of retinoids on the bioavailability of methoxy-8-psoralen].
Beani JC; Bonnot D; Berthod F; Boitard M; Reymond JL; Beriel H; Amblard P
Ann Dermatol Venereol; 1991; 118(4):273-5. PubMed ID: 2069337
[TBL] [Abstract][Full Text] [Related]
20. Calculation of 8-methoxypsoralen dose according to body surface area in PUVA treatment.
Sakuntabhai A; Diffey BL; Farr PM
Br J Dermatol; 1995 Dec; 133(6):919-23. PubMed ID: 8547045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
